ANDA 75842, held by Aarxion Anda Hlding. Oxaprozin.
As of Nov 13, 2026, ANDA 75842 (Oxaprozin), held by Aarxion Anda Hlding, was first approved by FDA on Apr 12, 2001, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 12, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Oxaprozin600MG ยท tablet;oral | Oxaprozin | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
